Retiro De Equipo (Recall) de Device Recall Jologic InPlex CF Molecular Test

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por Hologic, Inc.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
  • ID del evento
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
  • Fecha de inicio del evento
  • Estado del evento
  • País del evento
  • Fecha de finalización del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    System, cystic fibrosis transmembrane conductance regulator, gene mutation detection - Product Code NUA
  • Causa
    Complaints of false positive het mutations and leaking cards; could lead to unnecessary invasive testing during pregnancy and the associated risks of such invasive testing.
  • Acción
    Customer notification letters were sent 03/31/16. Customers were instructed to immediately discontinue the use of the affected lot numbers. If a HET or MUT result was reported with the affected lots, Hologic recommends that customers notify the recipient of the result and request the patient be retested with another test method. Any HET or MUT results that were previously retested and reported out as negative do not require further testing. The firm requests that customers segregate any remaining inventory of all affected lots listed on the Customer Response Form. After segregation is complete reconcile the number of units (ASR Card or IVD Molecular Test Kit) which remain in inventory upon receipt of notification against the number originally shipped to site, and destroy all remaining inventory of the affected lots. Document the following in the appropriate fields on the Customer Response Form: 1. If have zero of the affected products on hand check the first box. 2. If have some inventory of the affected products on hand check the second box and then document the quantity on hand below, in the Qty On-Hand column. Note: When counting the number of units remaining in inventory count each unit (ASR Card box or IVD Molecular Test Kit), whether partial or full, as a unit. 3. Print name, phone and email address, in case the firm needs to follow up. 4. Sign and date the form. Signing acknowledges compliance with this recall notification, including destroying all remaining inventory of the affected products. When this documentation is complete fax the CRF to Hologic Technical Support using fax number: 858-410-8250. Alternatively, you can scan the document(s) and email to Hologic Technical Support at If laboratory has shared any of the affected cards noted in the CRF with another laboratory contact Hologic Technical Support immediately using the phone number below, so that Hologic may contact the other laboratory t


  • Modelo / Serial
    Lot Numbers: C33xx C34xx C35xx (xx denotes sublots)
  • Clasificación del producto
  • Clase de dispositivo
  • ¿Implante?
  • Distribución
    Distributed in the states of OH, AL, IL, AZ, AR, NJ, TX, GA, CO, DE, NC, MI, FL, ME, CA, IN, OR, KS, KY, MO, WA, NY, OK, WV, CT, IA, LA, RI, MA, and PA, and in the country of Canada.
  • Descripción del producto
    Hologic InPlex CF Molecular Test (IVD); Catalog Number: 95-432.
  • Manufacturer


  • Dirección del fabricante
    Hologic, Inc, 10210 Genetic Center Dr, San Diego CA 92121-4362
  • Empresa matriz del fabricante (2017)
  • Source